Clinical trial
Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent…
NCT00004090 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00004090 |
|---|---|
| Title | Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors |
| Official title | Gemcitabine (10 mg/m2/Min) and Cisplatin: A Phase I Study |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | cisplatin, gemcitabine hydrochloride |
| Start date | Aug 1, 1999 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | Aug 30, 2004 |
| Last update posted | Jul 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: